Chargement en cours...
Erenumab: A novel calcitonin gene-related peptide receptor antagonist developed specifically for migraine prevention
Headaches and migraines continue to be a leading cause of suffering and disability. As per the Global Burden of Disease Survey conducted in 2010, the exact magnitude of the disease still is underestimated. Migraine alone continues to rank seventh as a cause of disability. Various therapeutic modalit...
Enregistré dans:
| Publié dans: | J Anaesthesiol Clin Pharmacol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wolters Kluwer - Medknow
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7047699/ https://ncbi.nlm.nih.gov/pubmed/32174669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/joacp.JOACP_3_19 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|